ARK Investment Management’s UroGen Pharma URGN Stock Holding History

ARK Investment Management’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.08M	Sell	115,545 -5,939	-5%	-$119K	0.02%	134
2025 Q4	$2.85M	Sell	121,484 -5,236	-4%	-$114K	0.02%	133
2025 Q3	$2.53M	Sell	126,720 -39,374	-24%	-$707K	0.02%	142
2025 Q2	$2.28M	Sell	166,094 -19,696	-11%	-$189K	0.02%	132
2025 Q1	$2.05M	Buy	185,790 +45,642	+33%	+$487K	0.02%	132
2024 Q4	$1.49M	Buy	140,148 +18,514	+15%	+$222K	0.01%	153
2024 Q3	$1.54M	Sell	121,634 -30,147	-20%	-$447K	0.01%	153
2024 Q2	$2.55M	Buy	151,781 +5,452	+4%	+$77.5K	0.02%	134
2024 Q1	$2.19M	Sell	146,329 -15,196	-9%	-$248K	0.02%	183
2023 Q4	$2.42M	Sell	161,525 -53,747	-25%	-$698K	0.01%	154
2023 Q3	$3.02M	Buy	215,272 +13,354	+7%	+$214K	0.02%	140
2023 Q2	$2.09M	Sell	201,918 -68,828	-25%	-$759K	0.01%	171
2023 Q1	$2.5M	Buy	270,746 +73,808	+37%	+$679K	0.02%	152
2022 Q4	$1.75M	Sell	196,938 -84,763	-30%	-$803K	0.02%	200
2022 Q3	$2.34M	Sell	281,701 -20,423	-7%	-$169K	0.02%	163
2022 Q2	$1.61M	Sell	302,124 -31,348	-9%	-$215K	0.01%	222
2022 Q1	$2.9M	Buy	333,472 +146,979	+79%	+$1.15M	0.01%	179
2021 Q4	$1.77M	Sell	186,493 -57,672	-24%	-$813K	0.01%	248
2021 Q3	$4.11M	Sell	244,165 -72,083	-23%	-$1.14M	0.01%	195
2021 Q2	$4.83M	Buy	316,248 +24,378	+8%	+$441K	0.01%	242
2021 Q1	$5.69M	Buy	291,870 +218,101	+296%	+$4.63M	0.01%	208
2020 Q4	$1.33M	Buy	73,769 +39,557	+116%	+$829K	﹤0.01%	203
2020 Q3	$660K	Sell	34,212 -12,996	-28%	-$294K	﹤0.01%	180
2020 Q2	$1.23M	Buy	47,208 +30,387	+181%	+$743K	0.01%	141
2020 Q1	$300K	Buy	16,821 +796	+5%	+$21.5K	0.01%	158
2019 Q4	$535K	Buy	16,025 +1,790	+13%	+$48.9K	0.01%	129
2019 Q3	$339K	Buy	14,235 +706	+5%	+$23.1K	0.01%	179
2019 Q2	$486K	Buy	13,529 +4,522	+50%	+$167K	0.01%	136
2019 Q1	$333K	Sell	9,007 -2,291	-20%	-$96K	0.01%	160
2018 Q4	$486K	Buy	11,298 +40	+0.4%	+$1.8K	0.02%	112
2018 Q3	$532K	Buy	11,258 +1,820	+19%	+$84.6K	0.02%	139
2018 Q2	$470K	Sell	9,438 -4,064	-30%	-$237K	0.02%	146
2018 Q1	$671K	Buy	13,502 +4,218	+45%	+$211K	0.03%	111
2017 Q4	$345K	Buy	+9,284	New	+$331K	0.03%	118